| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/05/2015 | WO2015031871A1 Substituted urea depsipeptide analogs as activators of the clpp endopeptidase |
| 03/05/2015 | WO2015031775A1 Methods and compositions for rna-guided treatment of hiv infection |
| 03/05/2015 | WO2015031393A1 Treatment of pediatric otic disorders |
| 03/05/2015 | WO2015031300A1 Antibacterial beta-lactones, and methods of identification, manufacture and use |
| 03/05/2015 | WO2015030605A1 Honey compositions |
| 03/05/2015 | WO2015030567A1 Improvements to a complementary formulation for counteracting adverse effects of cancer treatments and of treatments for some viral diseases |
| 03/05/2015 | WO2015030504A1 Pharmaceutical composition for prevention or treatment of toxoplasmosis, comprising anti-non-small cell lung cancer agent as active ingredient |
| 03/05/2015 | WO2015030197A1 Novel microbial product having antifungal activity |
| 03/05/2015 | WO2015030106A1 Compound having ggt inhibitory effect, and ggt-family enzyme inhibitor |
| 03/05/2015 | WO2015030057A1 Novel morpholine derivative or salt thereof |
| 03/05/2015 | WO2015029967A1 Antibody titer-increasing agent using lactic acid bacterium |
| 03/05/2015 | WO2015029263A1 Cleaning solution and manufacturing method therefor |
| 03/05/2015 | WO2015028901A1 A nanostructure for the vehiculation of gas and/or active ingredients and/or contrast agents and uses thereof |
| 03/05/2015 | WO2015028637A1 Novel drug formulation |
| 03/05/2015 | WO2015028548A1 Multivalent sialic acid derivates |
| 03/05/2015 | WO2015028104A1 Novel drug combination |
| 03/05/2015 | WO2015028095A1 Branimycin derivatives and their use for the treatment of bacterial infectious diseases |
| 03/05/2015 | WO2015028094A1 Branimycin derivatives and their use for the treatment of bacterial infectious diseases |
| 03/05/2015 | WO2015027959A1 Cyclic peptide compound, and preparation method, pharmaceutical composition and use thereof |
| 03/05/2015 | WO2015027848A1 Method of administering formulation comprising peramivir and/or derivative thereof |
| 03/05/2015 | WO2015027334A1 Antisense-based small rna agents targeting the gag open reading frame of hiv-1 rna |
| 03/05/2015 | WO2014110705A9 Heterocycle-substituted tetracyclic compounds and methods of use thereof for treatment of viral diseases |
| 03/05/2015 | DE102013109514A1 Reduktion der Zelltoxizität von Bakteriostatika mittels Farbstoffen Reduction of cell toxicity of antimicrobials using dyes |
| 03/04/2015 | EP2843048A1 NOVEL INTEGRIN alpha9beta1 LIGAND AND USES THEREOF |
| 03/04/2015 | EP2842966A1 Therapeutic agent for injury in epithelium and endothelium |
| 03/04/2015 | EP2842964A1 Virtual method of determining a modified mRNA sequence |
| 03/04/2015 | EP2842961A1 New carbamate glycolipid and use thereof |
| 03/04/2015 | EP2842569A1 One dose vaccination with Mycoplasma hyopneumoniae |
| 03/04/2015 | EP2842559A2 Compounds, compositions and methods for the treatment of viral infections and other medical disorders |
| 03/04/2015 | EP2841559A1 Glycoengineered outer membrane vesicles and use thereof as vaccines |
| 03/04/2015 | EP2841432A1 Tetrahydropyran dgat1 inhibitors |
| 03/04/2015 | EP2841426A1 Antibacterial quinoline derivatives |
| 03/04/2015 | EP2841425A1 Antibacterial quinoline derivatives |
| 03/04/2015 | EP2841409A1 Compounds for use as inhibitors of alternative oxidase or cytochrome bc1 complex |
| 03/04/2015 | EP2841162A1 A method of mitigating virus associated end-organ damage |
| 03/04/2015 | EP2841101A1 Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease |
| 03/04/2015 | EP2841088A2 Use of thymosin alpha for the treatment of sepsis |
| 03/04/2015 | EP2841085A1 Anti-oomycete activity of lipopolysaccharide (lps)-binding proteins/bactericidal/permeability-increasing proteins |
| 03/04/2015 | EP2841066A1 Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
| 02/26/2015 | WO2015027137A1 Improved synthesis of capuramycin and its analogues |
| 02/26/2015 | WO2015027056A1 NOVEL METHOD OF REDUCING ANTIGENIC DRIFT OR REASSORTMENT OF VIRUSES IN A HOST ANIMAL USING α- INTERFERON |
| 02/26/2015 | WO2015027021A1 Imide and acylurea derivatives as modulators of the glucocorticoid receptor |
| 02/26/2015 | WO2015026796A1 Heterocycle analogs of cai-1 as agonists of quorum sensing in vibrio |
| 02/26/2015 | WO2015026454A1 Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis c virus |
| 02/26/2015 | WO2015025962A1 Amidine compound or salt thereof |
| 02/26/2015 | WO2015025900A1 Anti-influenza virus-neutralizing antibody |
| 02/26/2015 | WO2015024932A1 Fowl adenovirus vaccine |
| 02/26/2015 | WO2015024484A1 New rabies vaccine and method for preparation thereof |
| 02/26/2015 | WO2015024389A1 Vancomycin derivative, and preparation method and application thereof |
| 02/26/2015 | WO2015024128A1 Anti-dandruff compositions, and methods of use thereof |
| 02/26/2015 | WO2015024060A1 Immunoreceptor modulation for treating cancer and viral infections |
| 02/26/2015 | WO2015024042A1 Immunoreceptor modulation for treating cancer and viral infections |
| 02/25/2015 | EP2839840A1 Recombinant trivalent vaccine against human influenza |
| 02/25/2015 | EP2839838A1 Fowl adenovirus vaccine |
| 02/25/2015 | EP2839835A1 Encapsulated formulation |
| 02/25/2015 | EP2838903A1 Methods and compositions for treating viral infections |
| 02/25/2015 | EP2838901A1 6- (4- (1 -amino- 3 -hydroxycyclobutyl) phenyl) - 5 - phenyl (furo, thieno or pyrrolo) [2, 3-d]pyrimidin- 4 - one derivatives for the treatment of cancer |
| 02/25/2015 | EP2838900A1 Compounds and methods for antiviral treatment |
| 02/25/2015 | EP2838569A1 Optimizing ungual treatment by quantitative autoradiography |
| 02/25/2015 | EP2838566A2 Optimised subcutaneous therapeutic agents |
| 02/25/2015 | EP2838558A1 Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor |
| 02/25/2015 | EP2838526A1 Materials and methods for prevention and treatment of viral infections |
| 02/25/2015 | EP2838524A1 Compositions for topical treatment of microbial infections |
| 02/25/2015 | EP2838519A2 Methods and compounds for treating proliferative disorders and viral infections |
| 02/24/2015 | US8962801 Neisseria porin proteins |
| 02/24/2015 | US8962550 Identification of inhibitors of a bacterial stress response |
| 02/24/2015 | US8962278 Compositions and methods for production of immunoglobulins |
| 02/24/2015 | US8962032 Modulator |
| 02/24/2015 | US8961989 Methods for producing an immune response to tuberculosis |
| 02/24/2015 | CA2728328C Treatment of antibiotic-resistant bacteria infection |
| 02/24/2015 | CA2670965C Influenza vaccine formulation |
| 02/24/2015 | CA2658633C Chiral compounds substituted with phosphonic acid ester functions or phosphonic acid functions |
| 02/24/2015 | CA2636288C Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists |
| 02/24/2015 | CA2602294C Heterobicylic inhibitors of hvc |
| 02/24/2015 | CA2479288C Process for producing cytotoxic lymphocyte |
| 02/19/2015 | WO2015023898A1 Linear peptide antibiotcs |
| 02/19/2015 | WO2015023879A1 Derivatives of uncialamycin, methods of synthesis and their use as antitumor agents |
| 02/19/2015 | WO2015022874A1 Hydrogen-containing antimicrobial agent |
| 02/19/2015 | WO2015022698A1 A compound, transitmycin, effective against bacterial and viral pathogens |
| 02/19/2015 | WO2015022351A1 Medicament comprising a pharmaceutical combination of dolutegravir, emtricitabine and tenofovir |
| 02/19/2015 | WO2015022297A1 Strain of lactobacillus pentosus as probiotic |
| 02/19/2015 | WO2015022263A1 Novel aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection |
| 02/19/2015 | WO2015022038A1 3-substituted cyclopentylamine derivatives |
| 02/19/2015 | WO2015021530A1 Antiviral methods and compositions comprising probiotic bacterial molecules |
| 02/19/2015 | DE10333245C5 Präbiotisch wirksame Pflanzenextrakte Prebiotic active plant extracts |
| 02/18/2015 | EP2836485A1 Conformationally constrained, fully synthetic macrocyclic compounds |
| 02/18/2015 | EP2836223A1 Probiotic bacteria |
| 02/18/2015 | EP2836202A1 Pharmaceutical composition containing an unsaturated fatty acid enriched with oxygen and an organic solvent |
| 02/18/2015 | EP2836196A1 Preparation for topical application to mucosa containing polyhexanide as active ingredient |
| 02/17/2015 | US8957031 Competitive inhibitors of invariant chain expression and/or ectopic clip binding |
| 02/17/2015 | US8957018 Recombinant human CC10 protein for treatment of influenza |
| 02/17/2015 | US8956662 Phenylephrine pharmaceutical formulations and compositions for colonic absorption |
| 02/17/2015 | US8956648 Calciumphosphate-based nanoparticles as carrier-systems for photodynamic therapy |
| 02/17/2015 | US8956629 Dental composition containing organic nanotube |
| 02/17/2015 | US8956605 Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22 |
| 02/17/2015 | CA2781780C Novel antiviral compounds |
| 02/17/2015 | CA2776522C Development of a preventive vaccine for filovirus infection in primates |
| 02/17/2015 | CA2704649C Tetracyclic dipyrano-coumarin compounds with anti-hiv and anti-mycobacterium tuberculosis activities |
| 02/17/2015 | CA2695419C Compositions and methods for microbe storage and delivery |
| 02/17/2015 | CA2686976C Probiotics in a pre- and/or post-surgical environment |